Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 52 entries
View as:

A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT00050843 Org: User:
Start: 08/31/01 End: 02/29/04 Due: 02/28/05

Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00055562 Org: User:
Start: 01/31/03 End: 12/31/04 Due: 12/31/05

Prevention of Restenosis Following Revascularization

Phase: N/A Priority: Normal
NCT ID: NCT00518284 Org: User:
Start: 01/31/08 End: 09/30/09 Due: 09/30/10

A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00179686 Org: User:
Start: 03/31/05 End: 07/31/06 Due: 07/31/07

Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibition and Induction on the Pharmacokinetics of CC-220 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02820935 Org: User:
Start: 07/31/16 End: 09/30/16 Due: 09/30/17

Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01744626 Org: User:
Start: 12/31/12 End: 12/31/15 Due: 12/31/16

Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT00074646 Org: User:
Start: 12/31/03 End: 06/30/05 Due: 06/30/06

A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00420849 Org: User:
Start: 11/30/06 End: 11/30/09 Due: 11/30/10

Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00107094 Org: User:
Start: 03/31/05 End: - Due: -

Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL)

Phase: N/A Priority: Normal
NCT ID: NCT00179660 Org: User:
Start: 08/31/05 End: 06/30/08 Due: 06/30/09

A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00478777 Org: User:
Start: 03/31/07 End: 08/31/09 Due: 08/31/10

A Study to Evaluate CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00446433 Org: User:
Start: 03/31/02 End: 12/31/03 Due: 12/31/04

Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00002157 Org: User:
Start: - End: - Due: -

Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy

Phase: N/A Priority: Normal
NCT ID: NCT00120120 Org: User:
Start: 01/31/05 End: 11/30/07 Due: 11/30/08

Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.

Phase: N/A Priority: Normal
NCT ID: NCT00319969 Org: User:
Start: 04/30/06 End: 01/31/09 Due: 01/31/10

First-in-human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of CC-90001

Phase: N/A Priority: Normal
NCT ID: NCT02110420 Org: User:
Start: 02/28/14 End: 09/30/14 Due: 09/30/15

A Pharmacokinetic And Pharmacodynamic Study Of Oral Lenalidomide (Revlimid) In Subjects With Low- Or Intermediate-1-Risk Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT00910858 Org: User:
Start: 01/31/05 End: 05/31/09 Due: 05/31/10

D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00047476 Org: User:
Start: 06/30/02 End: 03/31/04 Due: 03/31/05

A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas

Phase: N/A Priority: Normal
NCT ID: NCT00179751 Org: User:
Start: 04/30/05 End: 08/31/06 Due: 08/31/07

Effect of UV Exposure on the PD of Multiple Doses of CC-90001 and Pilot Food Effect Study

Phase: N/A Priority: Normal
NCT ID: NCT02321644 Org: User:
Start: 11/30/14 End: 02/28/15 Due: 02/28/16

A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00057564 Org: User:
Start: 02/28/03 End: 08/31/13 Due: 08/31/14

A Trial of ABI-007 in Patients With Advanced Non-Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00046423 Org: User:
Start: 04/30/00 End: - Due: -

Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1

Phase: N/A Priority: Normal
NCT ID: NCT00109772 Org: User:
Start: 02/28/05 End: 04/30/08 Due: 04/30/09

Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality

Phase: N/A Priority: Normal
NCT ID: NCT00179621 Org: User:
Start: 07/31/05 End: 06/30/10 Due: 06/30/11

Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00179647 Org: User:
Start: 09/30/05 End: 04/30/09 Due: 04/30/10